$LLY surges 10.33% to $1107.12 on heavy volume

$Eli Lilly(LLY)$

Eli Lilly and Company (LLY) Soared +10.33%: Bullish Breakout on Heavy Volume, $1141 Target in Sight

Latest Close Data:

Closed at $1107.12 on 2026-02-04, surging +10.33% ($103.66). The price is now just 2.37% below its 52-week high of $1133.95.

Core Market Drivers:

The massive single-day rally was fueled by significant net capital inflow of $1.71 billion, with strong buying across all order sizes.
Key weight-loss drugs like Mounjaro and Zepbound continue to dominate market sentiment and drive growth expectations, overshadowing broader market volatility.

Technical Analysis:

Volume exploded to 7.12M shares (Volume Ratio: 2.08), confirming the breakout power.
RSI(6) jumped sharply to 67.77, entering bullish territory but not yet overbought.
MACD shows a strong bullish reversal signal, with the DIF line (-0.84) crossing above the DEA line (-0.026), generating a fresh buy signal.

Key Price Levels:

Primary Support: $1065.00 (today's low & psychological level).
Strong Resistance: $1133.95 (52-week high).
Immediate Pivot: $1107.12 (today's close). Holding above this level is crucial for continued upward momentum.

Valuation Perspective:

Forward P/E stands at 30.20, significantly below its historical average of 51.94 and the -1 Std. Dev. of 34.24, suggesting the stock may be undervalued relative to its own history given current growth projections.

Analyst Targets:

30 analysts have an average price target of $1141.27 (upside ~3.1%). Sentiment is strongly bullish with 11 Strong Buy, 13 Buy, and 9 Hold ratings.

Weekly Outlook:

Expect consolidation near the $1100-$1135 range after the explosive move. A confirmed break above $1133.95 could open the path toward the $1200-$1250 zone.

A failure to hold $1100 may lead to a pullback toward $1077 (previous resistance turned support).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

To The Moon